New Challenges in Intra-articular Treatments
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 9475
Special Issue Editors
Interests: vitamin D; osteoporosis; sarcopenia; CRPS; musculoskeletal pain; neuromuscular diseases; lysosomal storage disorders
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Osteoarthritis is the most common degenerative joint disease and age-related condition in Western countries, resulting in significant pain, functional limitation, and poor social participation and quality of life. Despite its huge prevalence and economic burden, no curative intervention for osteoarthritis has been developed so far. Intra-articular injections of various agents are commonly prescribed to treat this condition, with conflicting evidence. On the other hand, an era of relevant scientific development is emerging in this therapeutic field, considering the improved knowledge of physiopathological pathways, the advances in the characterization of biomolecules, the increasing use of drugs previously administrated only through systemic routes and for which the opportunity of intra-articular treatment was foreseen, and the progress of precision medicine. The scope of this Special Issue is to critically underline perspectives and challenges of innovative intra-articular approaches.
Prof. Dr. Giovanni Iolascon
Dr. Alberto Migliore
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- injections
- intra-articular
- hyaluronic acid
- viscosupplementation
- tribosupplementation
- biological products
- intra-articular niche cells
- osteoarthritis
- clodronic acid
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.